The international society of cancer surgeons, publisher of Annals of Surgical Oncology and co-author of the margin and de-escalation guidelines that changed breast and melanoma surgery.
Founded in 1940 as the James Ewing Society, the SSO represents surgical oncologists worldwide, publishes Annals of Surgical Oncology and runs the annual SSO International Conference on Surgical Cancer Care. Its joint SSO-ASTRO consensus on breast-conserving surgery margins ('no ink on tumour') reduced re-excisions, and its guidelines with ASCO on sentinel node biopsy and melanoma surgery translated MSLT-II into practice. SSO accredits complex general surgical oncology fellowships and its Breast Surgical Oncology and Complex General Surgical Oncology training programmes, and it partners with ESSO and the Asian and Latin American societies on global surgical oncology.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to Society of Surgical Oncology, including child institutions. 49 works · 750 citations · 65% open access · 6% clinical trials · 4% reviews.
Massachusetts General Hospital surgical oncologist and 2026-2027 President of the Society of Surgical Oncology, with expertise in liver cancer and melanoma.
Breast surgeon whose margin and axillary guidelines cut unnecessary re-excisions and lymph node surgery worldwide.
Breast surgical oncologist at Winship Cancer Institute and President-Elect of the Society of Surgical Oncology, known for research on lobular breast cancer and surgical de-escalation.
Surgeon who has led Siteman since its founding and built it into a top NCI comprehensive centre.
Selwyn Vickers is a surgeon-scientist who leads the world's top-ranked cancer hospital.
Shares Annals of surgical oncology, European Society of Surgical Oncology, HR-positive / HER2-negative breast cancer.
Shares MSLT-II, Sentinel lymph node biopsy, Melanoma.
Shares European Society of Surgical Oncology, Sentinel lymph node biopsy, HR-positive / HER2-negative breast cancer.
Shares American Society for Radiation Oncology, Surgery and radiotherapy cure most, get least, HR-positive / HER2-negative breast cancer.
Shares Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least, HR-positive / HER2-negative breast cancer.
Shares Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least, Robotic & minimally invasive surgery.
Shares Sentinel lymph node biopsy, Surgery and radiotherapy cure most, get least, Robotic & minimally invasive surgery.
Shares Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least, HR-positive / HER2-negative breast cancer.